Scarica l'app Stockscreener
16.04
1.71%
0.27
Pre-mercato:
16.09
0.05
+0.31%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.77
Aprire:
$15.86
Volume 24 ore:
928.33K
Relative Volume:
0.89
Capitalizzazione di mercato:
$2.08B
Reddito:
$283.06M
Utile/perdita netta:
$287.20M
Rapporto P/E:
7.7223
EPS:
2.0771
Flusso di cassa netto:
$135.69M
1 W Prestazione:
+0.00%
1M Prestazione:
+2.75%
6M Prestazione:
+11.00%
1 anno Prestazione:
+94.19%
Intervallo 1D:
$15.67
$16.11
Intervallo di 1 settimana:
$14.83
$16.11
Portata 52W:
$7.285
$16.88
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Compare AUPH vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
16.04 | 2.08B | 283.06M | 287.20M | 135.69M | 2.0771 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-11-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-05 | Iniziato | Cowen | Outperform |
| 2020-01-10 | Iniziato | Jefferies | Buy |
| 2019-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Reiterato | FBR & Co. | Outperform |
| 2016-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
MSN Money - MSN
Pharma Co. Investor Sues Over Misleading Aurinia Deal - Law360
Short Interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Decreases By 15.7% - MarketBeat
AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum - ChartMill
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Kezar Life Sciences (NASDAQ: KZR) details Aurinia tender offer, pay and ownership - Stock Titan
Aurinia earnings on deck: Can new leadership sustain growth? By Investing.com - Investing.com India
Aurinia earnings on deck: Can new leadership sustain growth? - Investing.com
Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - MSN
Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - MSN
How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 By Investing.com - Investing.com India
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 - Investing.com Australia
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Aurinia (NASDAQ: AUPH) details 2026 virtual AGM, auditor and say-on-pay - Stock Titan
Aurinia (AUPH) Stock: Risk Exposure (Grinds Higher) 2026-04-18Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Aurinia (AUPH) Stock Breakout Watch (-1.37%) 2026-04-16Risk Analysis - UBND thành phố Hải Phòng
Tudor Investment Corp ET AL Buys Shares of 65,964 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month HighHere's What Happened - MarketBeat
Trading Systems Reacting to (AUPH) Volatility - Stock Traders Daily
Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan
Ideas Watch: Is Aurinia Pharmaceuticals Inc gaining market sharePortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Guidance Update: Does Aurinia Pharmaceuticals Inc stock have upside surprise potentialBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan
Dow Update: Whats the profit margin of Aurinia Pharmaceuticals Inc2026 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Proxy StatementNotice of Shareholders Meeting (preliminary) (pre 14a) - ADVFN
Ritholtz Wealth Management Acquires 174,301 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
AUPHAurinia Announces Results of Annual General Meeting - ADVFN
RSI Check: Can Aurinia Pharmaceuticals Inc grow without external fundingDip Buying & Short-Term High Return Ideas - baoquankhu1.vn
Downgrade Watch: Why is Aurinia Pharmaceuticals Inc stock going up2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Will Aurinia Pharmaceuticals Inc benefit from government policyEarnings Risk Report & Risk Managed Trade Strategies - baoquankhu1.vn
7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments - GlobeNewswire Inc.
Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm
AUPH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):